| 1. | | Recruiting | Androgen Effects in HIV-infected Women
Conditions: HIV Infection; HIV Wasting Syndrome |
| 2. | | Not yet recruiting | Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy Adults
Condition: West Nile Fever Encephalitis |
| 3. | | Not yet recruiting | Safety of and Immune Response to a Dengue Virus Vaccine (rDEN2/4delta30[ME]) in Healthy Adults
Condition: Dengue Fever |
| 4. | | Not yet recruiting | Evaluating Switching HIV Subject's Current Protease Inhibitor Therapies For A Fosamprenavir Therapy, Over 48 Weeks
Condition: HIV Infections |
| 5. | | Not yet recruiting | Short-Term Study Of A Once-Daily Fixed-Dose Combination Tablet In Antiretroviral-Naive HIV-1 Infected Subjects.
Condition: HIV Infections |
| 6. | | Not yet recruiting | HIV Assessment in Fuyang, Anhui Province, China
Condition: HIV Infections |
| 7. | | Recruiting | Study of Viramidine to Ribavirin in Patients with Chronic Hepatitis C Who are Treatment Naive
Condition: Chronic Hepatitis C |
| 8. | | Not yet recruiting | Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited Settings
Conditions: HIV Infections; Tuberculosis |
| 9. | | Recruiting | An Exploratory Study of AVI-4020 in Patients with Possible Acute Neuroinvasive West Nile Virus (WNV) Disease
Condition: West Nile Fever |
| 10. | | Recruiting | Safety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of HIV-infected Subjects
Condition: HIV Infection |
| 11. | | Recruiting | Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents
Conditions: HIV Infections; Influenza |
| 12. | | Not yet recruiting | Safety of and Immune Response to an HIV-1 Vaccine Boost (VRC-HIVADV014-00-VP) in HIV Uninfected Adults Who Participated in HVTN 052
Condition: HIV Infections |
| 13. | | Not yet recruiting | Nine Month Course of Anti-HIV Medications for People Recently Infected with HIV
Condition: HIV Infections |
| 14. | | Recruiting | Yoga for Treating People at Risk for Diabetes or With Both HIV and Depression
Conditions: HIV Infections; Diabetes; Depression |
| 15. | | Recruiting | Rotavirus Efficacy and Safety Trial (REST)
Condition: Rotavirus Infections |
| 16. | | Recruiting | Monotherapy Versus Placebo Over 7 Days-Non-Nucleoside Reverse Transcriptase Inhibitor-experienced HIV1 Infected Adults
Condition: HIV Infections |
| 17. | | Recruiting | Safety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy Adults
Condition: Dengue Fever |
| 18. | | Recruiting | TNX-355 with Optimized Background Therapy (OBT) in Treatment-Experienced Subjects with HIV-1
Condition: HIV Infections |
| 19. | | Recruiting | 48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection
Condition: HIV Infections |
| 20. | | Not yet recruiting | Optimal Treatment for Kidney Disease in HIV Infected Adults
Conditions: HIV Infections; Kidney Disease |
| 21. | | Not yet recruiting | NNRTI- Versus PI-Containing Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child Transmission of HIV
Condition: HIV Infections |
| 22. | | Recruiting | A phase II open-label, randomized, active-controlled study comparing the efficacy and safety of once daily Fuzeon (enfuvirtide) dosing versus the currently recommended twice daily dosing in HIV-1 infected treatment experienced patients.
Condition: HIV Disease |
| 23. | | Not yet recruiting | Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients
Condition: HIV Infections |
| 24. | | Recruiting | Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C
Conditions: Hepatitis C; Hepatitis |
| 25. | | Recruiting | Effect of Tenofovir DF on Bone Metabolism in Children
Condition: HIV Infections |
| 26. | | Recruiting | A Caspase Inhibitor in Chronic Hepatitis C (HCV) Patients
Condition: Hepatitis C, Chronic |
| 27. | | Recruiting | Blood Levels of Abacavir in HIV Infected Adolescents
Condition: HIV Infections |
| 28. | | Not yet recruiting | A Safety and Efficacy Study of Prophylactically Administered Pegylated Interferon alfa-2a (Pegasys) plus Ribavirin vs. No Prophylaxis Following Liver Transplantation for Hepatitis C
Condition: Hepatitis C |
| 29. | | Recruiting | Evaluation of the viral kinetics and pharmacokinetics of Pegasys plus Copegus and PEG-Intron plus Rebetol in patients with Chronic Hepatitis C and previously untreated with an interferon.
Condition: Hepatitis C |
| 30. | | Recruiting | Safety, feasibility and tolerability of Pegasys plus Copegus in previous intravenous drug users (IVDUs) who are infected with Chronic Hepatitis C and are currently enrolled in a methadone maintenance treatment program
Condition: Hepatitis C |
| 31. | | Recruiting | Efficacy and safety of Pegasys plus Copegus in patients with chronic Hepatitis C who are unable to tolerate or who do not respond to 12 weeks of therapy with PEG-Intron plus Rebetol/Ribavirin.
Condition: Hepatitis C |
| 32. | | Not yet recruiting | Three Month Course of Anti-HIV Medications for People Recently Infected with HIV
Condition: HIV Infections |
| 33. | | Not yet recruiting | BCX-1777 in Treating Patients With Recurrent or Refractory Advanced T-Cell Leukemia or T-Cell Lymphoma
Conditions: acute leukemia; adult T-cell leukemia and lymphoma; childhood lymphoblastic lymphoma; Non-Hodgkin's Lymphoma; Prolymphocytic Leukemia |
| 34. | | Recruiting | Daily dosing of Interferon Alfacon-1 plus Ribavirin for treatment of Hepatitis C Infected Patients (nonresponders)
Condition: Chronic Hepatitis C |
| 35. | | Recruiting | Long-term Follow-up of HIV Infected Patients Identified During Early Infection
Condition: HIV Infections |
| 36. | | Recruiting | Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV
Condition: HIV Infections |
| 37. | | Recruiting | HIV Study Of GW433908 Versus Kaletra, Both With Abacavir/lamivudine In Therapy-Naive Patients
Condition: HIV Infections |
| 38. | | Recruiting | Peginterferon alpha-2a and ribavirin to treat hepatitis C in HIV-infected patients
Conditions: Hepatitis C; HIV Infections |
| 39. | | Recruiting | Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy
Conditions: HIV Infections; Peripheral Nervous System Diseases; Pain |
| 40. | | Recruiting | CIFN and IFN γ-1b with or without Ribavirin for treatment of Chronic Hepatitis C (nonresponders)
Condition: Chronic Hepatitis C |
| 41. | | Recruiting | Safety of and Immune Response to Cyclosporine A in Combination with Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in Adults with Acute HIV Infection
Condition: HIV Infections |
| 42. | | Not yet recruiting | Once-Daily PI/NNRTI Therapy Combinations for Treatment Naive, HIV Infected Patients in Resource-limited Conditions
Condition: HIV Infections |
| 43. | | Recruiting | Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV
Condition: HIV Infections |
| 44. | | Not yet recruiting | Voluntary HIV Counseling, Testing, and Medication for Pregnant Women to Prevent Mother-to-Child HIV Transmission
Condition: HIV Infections |
| 45. | | Not yet recruiting | Anti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIV
Condition: HIV Infections |
| 46. | | Recruiting | Atazanavir/Ritonavir Maintenance Therapy
Condition: HIV Infections |
| 47. | | Not yet recruiting | Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults
Condition: HIV Infections |
| 48. | | Recruiting | Safety and Immunogenicity of an HIV Vaccine in Normal Adult Volunteers
Conditions: Healthy; HIV Infections |
| 49. | | Recruiting | Treatment of Abnormal Adipose Tissue Accumulation in HIV Patients
Conditions: HIV Infections; Lipodystrophy |
| 50. | | Recruiting | Safety and Effectiveness of the Oral HIV Entry Inhibitor SCH 417690 in HIV Infected Patients
Condition: HIV Infections |
